home / stock / aurx / aurx quote
Last: | $0.80 |
---|---|
Change Percent: | 0.0% |
Open: | $0.8 |
Close: | $0.80 |
High: | $0.8 |
Low: | $0.8 |
Volume: | 4,366 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.8 | $0.8 | $0.8 | $0.8 | $0.8 | 4,366 | 05-01-2024 |
$0.8 | $0.8 | $0.8 | $0.8 | $0.8 | 500 | 04-25-2024 |
$0.8 | $0.8 | $0.8 | $0.8 | $0.8 | 3,460 | 04-23-2024 |
$0.8 | $0.85 | $0.8 | $0.85 | $0.79265 | 20,062 | 04-18-2024 |
$0.75 | $0.75 | $0.75 | $0.75 | $0.75 | 26,000 | 04-17-2024 |
$0.95 | $0.9499 | $0.95 | $0.95 | $0.9499 | 1,000 | 04-11-2024 |
$0.95 | $0.95 | $0.95 | $0.95 | $0.95 | 300 | 04-08-2024 |
$0.95 | $0.95 | $0.95 | $0.95 | $0.95 | 3,817 | 04-04-2024 |
$0.98 | $0.98 | $0.98 | $0.98 | $0.98 | 1,623 | 04-01-2024 |
$0.9 | $0.9 | $0.9 | $0.9 | $0.9 | 1,000 | 03-26-2024 |
$0.9 | $0.9 | $0.9 | $0.9 | $0.9 | 6,657 | 03-21-2024 |
$0.9 | $0.9 | $0.9 | $0.9 | $0.9 | 1,280 | 03-20-2024 |
$0.9 | $0.9 | $0.9 | $0.9 | $0.9 | 3,300 | 03-18-2024 |
$0.8999 | $0.89 | $0.8999 | $0.9 | $0.88 | 10,626 | 03-15-2024 |
$0.9 | $0.9 | $0.9 | $0.9 | $0.9 | 2,171 | 03-12-2024 |
$0.9 | $0.9 | $0.9 | $0.9 | $0.9 | 2,500 | 03-08-2024 |
$0.877 | $0.797 | $0.877 | $0.877 | $0.797 | 1,502 | 03-06-2024 |
$0.65 | $0.52 | $0.65 | $0.65 | $0.52 | 3,000 | 03-04-2024 |
$0.65 | $0.65 | $0.65 | $0.6825 | $0.65 | 18,000 | 03-01-2024 |
$0.65 | $0.65 | $0.65 | $0.65 | $0.65 | 600 | 02-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
AUDEO ONCOLOGY INC. Company Name:
AURX Stock Symbol:
OTCMKTS Market:
HOUSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, announced today it has been sel...
HOUSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, is pleased to announce that W...
Broad equity incentive agreement established with Pacific Medical, Inc. including initial equity purchase Favorable initial progress on establishing substantive distribution network in support of commercial goals for Aurix Foundational Aurix product is well positioned wi...